2. Academic Validation
  3. A split intein and split luciferase-coupled system for detecting protein-protein interactions

A split intein and split luciferase-coupled system for detecting protein-protein interactions

  • Mol Syst Biol. 2025 Feb;21(2):107-125. doi: 10.1038/s44320-024-00081-2.
Zhong Yao 1,  Jiyoon Kim 2,  Betty Geng 2,  Jinkun Chen 2,  Victoria Wong 2,  Anna Lyakisheva 2,  Jamie Snider 2,  Marina Rudan Dimlić 3,  Sanda Raić 3,  Igor Stagljar 4 5 6 7
Affiliations

Affiliations

  • 1 Donnelly Centre, University of Toronto, Toronto, ON, Canada. zhong.yao@utoronto.ca.
  • 2 Donnelly Centre, University of Toronto, Toronto, ON, Canada.
  • 3 Mediterranean Institute for Life Sciences, University of Split School of Medicine, Split, Croatia.
  • 4 Donnelly Centre, University of Toronto, Toronto, ON, Canada. igor.stagljar@utoronto.ca.
  • 5 Mediterranean Institute for Life Sciences, University of Split School of Medicine, Split, Croatia. igor.stagljar@utoronto.ca.
  • 6 Department of Biochemistry, University of Toronto, Toronto, ON, Canada. igor.stagljar@utoronto.ca.
  • 7 Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada. igor.stagljar@utoronto.ca.
PMID: 39668253 DOI: 10.1038/s44320-024-00081-2
Abstract

Elucidation of protein-protein interactions (PPIs) represents one of the most important methods in biomedical research. Recently, PPIs have started to be exploited for drug discovery purposes and have thus attracted much attention from both the academic and pharmaceutical sectors. We previously developed a sensitive method, Split Intein-Mediated Protein Ligation (SIMPL), for detecting binary PPIs via irreversible splicing of the interacting proteins being investigated. Here, we incorporated tripart nanoluciferase (tNLuc) into the system, providing a luminescence signal which, in conjunction with homogenous liquid phase operation, improves the quantifiability and operability of the assay. Using a reference PPI set, we demonstrated an improvement in both sensitivity and specificity over the original SIMPL assay. Moreover, we designed the new SIMPL-tNLuc ('SIMPL2') platform with an inherent modularity allowing for flexible measurement of molecular modulators of target PPIs, including inhibitors, Molecular Glues and PROTACs. Our results demonstrate that SIMPL2 is a sensitive, cost- and labor-effective tool suitable for high-throughput screening (HTS) in both PPI mapping and drug discovery applications.

Keywords

Drug Discovery; Inhibitor; Protein-protein Interaction; Split Intein; Tri-part Nanoluciferase.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z